A wrongful-death case does not require the decedent to have been in perfect health. A defendant who takes a life cannot escape liability simply because that life would have been shorter than average. The operative principle is straightforward: the tortfeasor took away whatever remaining time the decedent had, and those survivors are entitled to compensation for that loss. What changes when the decedent had a terminal or life-limiting diagnosis is not whether recovery is available but how it is measured, and how you answer the defense's inevitable-death argument at every stage of litigation from depositions to closing argument.
The Legal Framework
All states allow wrongful-death recovery for the death of a terminally ill plaintiff. The death must have been caused or accelerated by the defendant's negligence, not merely correlated with it. That requirement, familiar from any wrongful-death case, is the first point of attack: the defense will argue that the decedent died from the underlying disease, not from the defendant's conduct. Expert testimony is essential to establishing that the negligent act caused the death to occur earlier than it otherwise would have, or that it changed the manner and circumstances of dying in a way that harmed survivors independently of when death would have occurred.
The distinction between shortening life and causing death is conceptual but important. If a decedent with a terminal cancer diagnosis is killed in a car crash, the defendant caused a specific death at a specific time that would not have occurred then in the absence of the crash. The cancer is not a defense; it is a factor in damages calculation. Across jurisdictions, courts have consistently rejected the argument that a defendant who kills a terminally ill person owes little or nothing because the person would have died anyway. The lost time is the measure of the harm.
Expert Testimony on Projected Survival
Calculating economic and non-economic damages requires a credible projection of how long the decedent would have lived but for the defendant's negligence. This requires a treating physician or specialist in the relevant condition to provide a projected survival range based on the disease's stage, the decedent's response to treatment at the time of death, and published actuarial data for the condition.
For some conditions, that projection is relatively precise. A Stage II non-Hodgkin's lymphoma with confirmed remission at the time of the crash carries a well-documented five-year survival distribution. For other conditions, the range is wide. Where the defense will contest the projection, retain more than one expert, including an oncologist or specialist and an economist who can build damage models across a range of projected survival periods. Presenting a best-case, median, and worst-case projection for the jury to evaluate is often more persuasive than a single point estimate that the defense attacks as speculative.
Economic Damages: The Shortened-Period Model
Lost earnings and support calculations are constrained by the projected survival period. If the decedent would have worked for two more years under the realistic survival projection, that two-year window is the economic loss period for earnings. But two years of foregone wages at a professional income level is a material number, and the economic expert should present it in that light rather than apologizing for the truncated period.
Loss of household services, which courts frequently allow and which are often undervalued by plaintiff counsel, may also be calculated over the projected survival period. For decedents who provided substantial in-home support to family members, particularly children or a disabled spouse, the quantified value of those lost services adds meaningfully to the economic damages picture.
Pre-death medical expenses in the survival action are not subject to the terminal-diagnosis discount. If the defendant's negligence caused a period of pain, treatment, and suffering before death, those costs are recoverable in full regardless of the underlying condition's natural trajectory.
Non-Economic Damages: No Discount for Terminal Status
Loss of companionship, society, and consortium for surviving family members is not diminished by the decedent's terminal diagnosis in most jurisdictions. The argument that a shorter remaining relationship carries a proportionally lower loss-of-consortium value is not a legal standard and has been repeatedly rejected as an argument for dismissal or judgment as a matter of law. Juries value the companionship of a parent, spouse, or child based on the quality of the relationship and the reality of the loss, not an actuarial reduction. The defendant's attorney will argue this in closing, not before. Anticipate it and prepare witnesses to explain what they lost in terms a jury can feel, not a discount a spreadsheet produces.
Answering the Inevitable-Death Defense
Defense counsel will present some version of the following argument: this person was dying anyway, the jury should not hold us responsible for a few months that were already lost to disease, and any award should reflect only the marginal acceleration of an inevitable event. The counters are:
- The acceleration of death is itself a legally cognizable harm, and courts have consistently recognized that taking a terminally ill person's remaining time away creates compensable damages. The lost period is not marginal if the family had plans for it, if the decedent was receiving effective treatment and maintaining quality of life, and if survivors depended on the decedent for support or care during that period.
- The defense's projection of how long the decedent would have lived is exactly as speculative as the plaintiff's. When the defense claims the decedent had only weeks left, require specific evidence: physician testimony, treatment records, and diagnostic data that support that position. Generalizations about prognosis do not reduce damages without specific, admissible expert support.
- Where the decedent was in remission or responding to treatment at the time of death, challenge any assumption of imminent natural death directly. A patient in active treatment who responds well to therapy may have years, not months, remaining. The terminal label attached to a diagnosis is not a fixed expiration date, and your medical expert should say so clearly.
For the damages model structure in wrongful-death cases generally, see lawyerstrend.com/category/wrongful-death. Where the terminal condition was caused or accelerated by prior medical treatment, a parallel med-mal claim may exist; see lawyerstrend.com/category/medical-malpractice. For case value benchmarks in catastrophic injury and wrongful-death matters, see lawyerstrend.com/category/case-law-settlements.